NLS Pharmaceutics (NLSP) has released an update.
NLS Pharmaceutics Ltd. has announced a change in the record date for its extraordinary general meeting, now set for September 9, 2024, due to a delay in invitation dispatch. The company has also been granted an extension by Nasdaq until October 14, 2024, to meet listing requirements, including a minimum bid price and stockholders’ equity, after presenting a compliance plan at a hearing on June 4, 2024.
For further insights into NLSP stock, check out TipRanks’ Stock Analysis page.
